Table 1. Patient demographics and tumor characteristics.
| Characteristic | Types | N | Age (years) | P value | Sex | P value |
|---|---|---|---|---|---|---|
| WHO classification | ||||||
| Low risk thymoma | A | 2 | 60 [27–76] | 0.433* | Male 9; female 19 | 0.001# |
| AB | 13 | |||||
| B1 | 13 | |||||
| High risk thymoma | B2 | 11 | 65 [31–81] | Male 3; female 14 | ||
| B3 | 6 | |||||
| Thymic carcinoma | 16 | 62.5 [30–79] | Male 12; female 4 | |||
| Total | 61 | 59 [27–81] | Male 24; female 37 | |||
| Comorbidities in patients with thymoma | ||||||
| Myasthenia gravis | 11 | |||||
| Rheumatoid arthritis | 1 | |||||
| Systemic sclerosis | 1 |
Data are presented as the number or the mean [range]. *, there were no significant differences in the distribution of age between thymoma (low risk and high risk) and thymic carcinoma; #, there was a significant difference in the distribution of sex between thymoma (low risk and high risk) and thymic carcinoma. WHO, World Health Organization.